NCT02410811View on ClinicalTrials.gov

Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

January 29, 2018

Study Completion Date

May 20, 2019

Conditions
Sickle Cell Disease
Interventions
OTHER

Cardiac magnetic resonance imaging (CMR)

CMR is obtained on all participants in all arms/groups

Trial Locations (1)

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

All Listed Sponsors
lead

Children's Hospital Medical Center, Cincinnati

OTHER

NCT02410811 - Novel Cardiac Magnetic Resonance Imaging to Define a Unique Restrictive Cardiomyopathy in Sickle Cell Disease | Biotech Hunter | Biotech Hunter